/
Launched in 2017, Hims & Hers Health, Inc. (and together with its subsidiaries, Hims & Hers , the Company , we , us or our ) has built a consumer-first platform transforming the way customers fulfill their health and wellness needs. We believe that the Company has the technical infrastructure, distributed provider network, and access to clinical capabilities to lead the migration of ro…
$27.51
$0.25 (-0.90%)
Last close via Marketstack
Operating margin is thin at 4.50%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 59.0%, still solid. Free cash flow declined 71% despite revenue growth, conversion is weakening.
Free cash flow declined 71% versus the prior year, cash generation momentum has weakened. ROIC dropped from 11.62% to 7.76%, capital efficiency is deteriorating.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$2.37B
▲ +59.0% YoY
Net Income (TTM)
-$13M
▲ +1.8% YoY
Op. Margin
-1.29%
▲ +0.3pp YoY
ROIC
-1.48%
▼ -3.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$60M
▼ -71.0% YoY
Op. Cash Flow (TTM)
$280M
▲ +19.5% YoY
Net Debt
$381M
Cash & Equiv.
$751M
5Y CAGR: +73.6%
Continue Research